WellStart Reboot Study



Status:Not yet recruiting
Conditions:Diabetes, Diabetes
Therapuetic Areas:Endocrinology
Healthy:No
Age Range:18 - 65
Updated:11/9/2018
Start Date:December 1, 2018
End Date:July 1, 2020
Contact:David S Drozek, DO
Email:drozek@ohio.edu
Phone:678-447-2509

Use our guide to learn which trials are right for you!

WellStart Type 2 Diabetes Study

This is a randomized, controlled comparison study that will evaluate the effectiveness of
WellStart, a virtual intensive therapeutic lifestyle change program to control type 2
diabetes.

Purpose: To test the efficacy of WellStart Health program to to arrest and / or reverse type
2 diabetes.

Future comparative studies between programs programs are anticipated, utilizing this data to
help identify the strengths and weaknesses of different programs, as well as identify
subpopulations that might benefit from one program as opposed to another.

Data from this study will be shared via posters and papers among the lifestyle medicine
community / publications to help contribute to better lifestyle interventions.

Pilot programs reported on the WellStart web page report reduction in hemoglobin A1c (HBA1c)
and weight during the 12 week program.

The web site states:

Evidence for the Program:

The 12-week lifestyle medicine program provides online health coaching and education on 5
domains of wellbeing: whole food, plant-forward nutrition, movement, mindset and social
support and resilience. The pilot programs have shown a mean weight reduction of 6.9 lbs in
85% of participants of the 12-week program. 85% of participants with prediabetes experienced
a reduction in hemoglobin A1c, while 100% of those with diabetes had a mean hemoglobin A1c
reduction of 1.1. WellStart has also helped 35% of participants on pharmacotherapy, eliminate
medication (antihypertensives and metformin).

Studies have shown the ability of plant-based nutrition to reverse chronic disease including
coronary artery disease. The BROAD study found a statistically significant reduction in BMI
and cholesterol in those following a plant-based diet. Furthermore, Dean Ornish's research
showed regression of coronary atherosclerosis after 5 years of a plant-based diet in addition
to lifestyle changes and found that it reduced cardiac events by half. Caldwell Esselstyn's
research on a whole food plant-based diet also demonstrated a significant reduction in major
cardiac events in adherent patients.

Furthermore, a 2016 comprehensive literature review supports a plant-based diet as medical
nutrition therapy for diabetes based on its ability to reduce fasting blood glucose,
hemoglobin A1c, body mass index and reduce medication use.

The Diabetes Prevention Program (DPP), a lifestyle and diet intervention program, reduces the
risk of diabetes by half in a population at risk. It has been successfully adapted to the
online setting. WellStart is taking this concept a step further by providing participants
with additional education and support to transition to plant-forward nutrition habits.

Inclusion Criteria:

- Established diagnosis of type 2 diabetes (T2DM)

- Between the ages of 18 and 65 years-old

- Own and willing to use a smart phone or computer, and have daily internet access

- Have an email account

- Have access to resources (finances and transportation) that allow for regular
acquisition (at least once weekly) of groceries, including produce

- Access to resources that allow for food preparation at home (refrigeration, basic
kitchen appliances and supplies)

- Willingness to attempt changes in food preparation and consumption, and physical
activity.

-Scoring at least a 7/10 in both readiness for change and confidence of success; 1= not
ready / no confidence; 10 = extremely ready / extremely confident of success -

Exclusion Criteria:

- Dementia

- Advanced renal disease (stage 4 or 5) with or without hemodialysis

- Congestive Heart Failure

- Taking warfarin

- Pregnancy or plans for pregnancy

- Current smoker of tobacco cigarettes

- Adults who have a physical limitation to prepare their own food or incorporate
movement into their lifestyle (based on questionnaire answer)

- Brittle diabetes and/or history of hospitalization for high or low blood sugar

- Difficult-to-control hypertension and / or on 4 or more medications for high blood
pressure.

- Does not speak or understand English

- Inability to use email or the Internet
We found this trial at
1
site
Athens, Ohio 45701
Principal Investigator: David S Drozek, DO
Phone: 678-447-2509
?
mi
from
Athens, OH
Click here to add this to my saved trials